Stefan Oelrich

Stefan Oelrich has been a member of the Board of Management of Bayer AG and head of the Pharmaceuticals Division, headquartered in Berlin, Germany, since November 1, 2018.

After graduating from high school in Paris, France, he joined Bayer AG as a commercial trainee in 1989 and qualified as a commercial assistant in 1991. Over the next 20 years, he held a number of positions of increasing responsibility in the health care business in Latin America, Europe, and the United States. In 2011, he joined Sanofi as General Manager in Germany, Switzerland, and Austria. In 2015, Oelrich became head of Sanofi’s Diabetes and Cardiovascular business unit in Europe. In 2017, was appointed Executive Vice President Diabetes & Cardiovascular on the Executive Committee of Sanofi. Since 2016, Oelrich has been a member of the Supervisory Board of the Berlin Institute of Health.